Filing Details
LIPELLA PHARMACEUTICALS INC. (NASDAQ:LIPO) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
8k filedNASDAQ:LIPO
LIPELLA PHARMACEUTICALS INC. (LIPO) Reports Material Event to SEC
Filing Details LIPELLA PHARMACEUTICALS INC. (NASDAQ:LIPO) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market…
Market Context
LIPELLA PHARMACEUTICALS INC.'s stock currently trades at $0.07 with a market capitalization of $1.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for LIPELLA PHARMACEUTICALS INC.'s stock.
All SEC filings for LIPELLA PHARMACEUTICALS INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LIPO Stock Page
Frequently Asked Questions
Where can I read LIPO's SEC filings?
Browse all filings on our LIPO SEC filings page.
What types of SEC filings does LIPELLA PHARMACEUTICALS INC. file?
Public companies like LIPELLA PHARMACEUTICALS INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.